DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 USD 170.75 BN MARKET SIZE, 2033 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period
This hormone, glucagon-like peptide-1, plays a key role in regulating: blood sugar insulin release appetite digestion GLP-1 medications treat Type 2 diabetes and obesity
Nutri Advanced L-Carnitine - 60 capsules MRP: 8,155.00 Price: 6,504.00 Nutri Advanced L-Carnitine provides 500mg of this amino acid compound in a easy to swallow capsule
Jada and her team focus on helping you make informed, sustainable changes
We should expect Novo Nordisk and Lilly to increase competitive intensity in 2025, while more markets will see head-on competition between the two as better supply allows semaglutide and tirzepatide to be launched in more countries
